drugset / Trial / NCT00822679
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
Phase 4
Completed
5 enrolled
University of Arizona
Southern Arizona VA Health Care System · collabSumitomo Pharma America, Inc. · collab
RandomizedParallel-groupDouble-blindSupportive care
Summary
The purpose of the study is to examine the effects of Eszopiclone, a sleep aid, on inflammatory mediators and coagulability in patients with a recent myocardial infarction.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-08
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 2 mg | Oral |
| Subject | Eszopiclone | Small molecule | 3 mg | Oral |